Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rotrosen

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Drug and Alcohol Dependence|May 23, 2022
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexoneJudith I Tsui, Aimee N C Campbell, Martina Pavlicova, et al.
Journal of General Internal Medicine|August 16, 2019
Screening for Substance Use in Rural Primary Care: a Qualitative Study of Providers and PatientsElizabeth C Saunders, Sarah K Moore, Trip Gardner, et al.
Journal of Clinical Pharmacology|January 25, 2006
Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trialsDomenic A Ciraulo, Robert J Hitzemann, Eugene Somoza, et al.
Substance Use & Misuse|April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT TrialKenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.
Addiction (Abingdon, England)|December 19, 2020
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variablesKara E Rudolph, Iván Díaz, Nima S Hejazi, et al.
Substance Abuse|May 12, 2006
A placebo controlled, double-blind study of mecamylamine treatment for cocaine dependence in patients enrolled in an opiate replacement programMalcolm S Reid, Burt Angrist, Sherryl A Baker, et al.
Addiction (Abingdon, England)|February 27, 2025
State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onsetIgnacio Bórquez, Arthur R Williams, Mei-Chen Hu, et al.
Biological Psychiatry|January 22, 2011
Reduced interhemispheric resting state functional connectivity in cocaine addictionClare Kelly, Xi-Nian Zuo, Kristin Gotimer, et al.
Journal of Addictive Diseases|February 7, 2009
Substance abuse treatment clinician opinions and infectious disease service deliveryKathlene Tracy, Lawrence S Brown, Steven Kritz, et al.
Psychiatry Research|October 31, 2006
Medication status affects the relationship of symptoms to prepulse inhibition of acoustic startle in schizophreniaErica J Duncan, Annie M Bollini, Barbara Lewison, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Drug and Alcohol Dependence|May 23, 2022
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexoneJudith I Tsui, Aimee N C Campbell, Martina Pavlicova, et al.
Journal of General Internal Medicine|August 16, 2019
Screening for Substance Use in Rural Primary Care: a Qualitative Study of Providers and PatientsElizabeth C Saunders, Sarah K Moore, Trip Gardner, et al.
Journal of Clinical Pharmacology|January 25, 2006
Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trialsDomenic A Ciraulo, Robert J Hitzemann, Eugene Somoza, et al.
Substance Use & Misuse|April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT TrialKenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.
Addiction (Abingdon, England)|December 19, 2020
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variablesKara E Rudolph, Iván Díaz, Nima S Hejazi, et al.
Substance Abuse|May 12, 2006
A placebo controlled, double-blind study of mecamylamine treatment for cocaine dependence in patients enrolled in an opiate replacement programMalcolm S Reid, Burt Angrist, Sherryl A Baker, et al.
Addiction (Abingdon, England)|February 27, 2025
State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onsetIgnacio Bórquez, Arthur R Williams, Mei-Chen Hu, et al.
Biological Psychiatry|January 22, 2011
Reduced interhemispheric resting state functional connectivity in cocaine addictionClare Kelly, Xi-Nian Zuo, Kristin Gotimer, et al.
Journal of Addictive Diseases|February 7, 2009
Substance abuse treatment clinician opinions and infectious disease service deliveryKathlene Tracy, Lawrence S Brown, Steven Kritz, et al.
Psychiatry Research|October 31, 2006
Medication status affects the relationship of symptoms to prepulse inhibition of acoustic startle in schizophreniaErica J Duncan, Annie M Bollini, Barbara Lewison, et al.
Pageof 16